menu search

Moderna may be facing its toughest moment ever. time to sell?

Moderna reported a billion-dollar loss in the third quarter and began downsizing its manufacturing infrastructure to match lower levels of v...

November 4, 2023, 5:00 am

Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance

In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer v...

November 3, 2023, 8:30 pm

Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance

In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer v...

November 3, 2023, 8:30 pm

Moderna ceo discusses earnings and how the company aims to break even by 2026

While boasting a third-quarter revenue beat, biotech firm Moderna (MRNA) reported an overwhelmingly higher-than-expected loss of $9.53 per share. Its ...

November 2, 2023, 6:24 pm

Moderna shares slide after posting a loss on falling covid-19 vaccine sales and production

Moderna (MRNA) shares tumbled over 6% Thursday after reporting a steep loss as the drug maker lost sales and cut back on making its COVID-19 v...

November 2, 2023, 4:55 pm

Ocugen to host conference call on thursday, november 9 at 8:30 a.m. et to discuss business updates and third quarter 2023 financial results

MALVERN, Pa., Nov. 02, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, ...

November 2, 2023, 11:30 am

Moderna stock plummets on 3q loss and weak sales guidance

Moderna Therapeutics Inc (NASDAQ:MRNA) stock moved lower on Thursday after the drugmaker's weak full-year sales forecast and a significant loss for th...

November 2, 2023, 11:27 am

Novavax to host conference call to discuss third quarter 2023 financial results and operational highlights on november 9, 2023

GAITHERSBURG, Md. , Nov. 2, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based v...

November 2, 2023, 9:25 am

Moderna revenue tops expectations, expects to return to sales growth in 2025

Moderna on Thursday said it expected 2023 revenue of at least $6 billion, a decline reflecting weaker demand for COVID-19 v...

November 2, 2023, 6:35 am

Hillevax to present at upcoming investor conferences

BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commerci...

November 1, 2023, 4:48 pm

Gsk beats on q3 earnings and sales, raises 2023 guidance

GSK's revenues benefit from strong growth across the Specialty Medicines and Vaccines segments. The com...

November 1, 2023, 12:47 pm

Gsk receives a mixed city reaction despite raised outlook

GSK PLC (LSE:GSK, NYSE:GSK) has received mixed reactions from City analysts despite an objectively strong third-quarter performance and raised financi...

November 1, 2023, 12:03 pm

Gsk boosts profit forecasts after ‘outstanding' rsv vaccine launch

High demand for the vaccine pulled in around $850 million during the third quarter—reportedly double ...

November 1, 2023, 6:38 am

Unlike pfizer, moderna can meet 2023 covid forecast, analysts say

Moderna should hit the lower end of its sales target for this year as it only needs to tap a small portion of the private market with its COVID v...

November 1, 2023, 6:03 am

Wework shares plunge on report of looming bankruptcy as match group stock slumps on tinder owner's israel warning

Novovax Inc. NVAX shares jumped 3% after the U.S. pharma firm's new COVID vaccine gained approval in th...

November 1, 2023, 5:34 am

Scancell melanoma trial data chosen for poster presentation at sitc

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) told investors that it has been selected for a poster presentation of data from the first stage of its Pha...

November 1, 2023, 4:16 am

Gsk raises outlook amid strong demand for new rsv vaccine

GSK PLC (LSE:GSK, NYSE:GSK) said a strong third quarter performance has driven a further upgrade to full-year guidance boosted by demand for its respi...

November 1, 2023, 3:31 am

Gsk raises annual forecasts again on strong arexvy launch

GSK raised its full-year profit and sales forecasts on Wednesday for the second time this year, betting on the strong launch of its respiratory syncyt...

November 1, 2023, 3:05 am

Pfizer quarterly results hit by soft demand for covid-19 products

Sales of the company's coronavirus vaccine Comirnaty dropped 70% during the third quarter compared with...

October 31, 2023, 8:20 pm

Gsk reports earnings wednesday. what to watch.

The company will for the first time report sales of Arexvy, its new RSV vaccine that launched this fall...

October 31, 2023, 5:00 pm


Search within

Pages Search Results: